INCB047986 in Rheumatoid Arthritis

An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis

NCT00383188 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RA

NCT00747214 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of a Monoclonal Antibody for Treatment of Rheumatoid Arthritis.

NCT00034203 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

NCT01370902 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)

NCT02858492 ·Status: COMPLETED ·Phase: PHASE2

A Study of SPY072 in Rheumatic Disease

NCT07148414 ·Status: RECRUITING ·Phase: PHASE2

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

NCT00847613 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients

NCT01559103 ·Status: TERMINATED ·Phase: PHASE1

Three Dose Levels of CP-690,550 Monotherapy Versus Placebo, Administered Orally Twice Daily (BID) for 6 Weeks

NCT00147498 ·Status: COMPLETED ·Phase: PHASE2

Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients

NCT00669942 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects

NCT02705989 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis

NCT02176876 ·Status: COMPLETED ·Phase: PHASE1

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

NCT02277574 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects

NCT02211469 ·Status: COMPLETED ·Phase: PHASE1

A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

NCT00152386 ·Status: COMPLETED ·Phase: PHASE3

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

NCT01888874 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

NCT00299546 ·Status: COMPLETED ·Phase: PHASE3

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

NCT00113308 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

NCT06754462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

NCT04985812 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis

NCT00674635 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis

NCT02638948 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 AMG 714 in Rheumatoid Arthritis

NCT00433875 ·Status: COMPLETED ·Phase: PHASE2

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis

NCT01647451 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

NCT00380744 ·Status: COMPLETED ·Phase: PHASE1/PHASE2